Among adolescents with Crohn disease not responding to treatment, use of the drug thalidomide resulted in improved clinical remission after 8 weeks of treatment compared with placebo. This is according to a study appearing in the November 27 issue of iJAMA/i. As many as 1.2 million people in Europe and more than half a million in the United States are estimated to have Crohn disease, a chronic inflammatory disease involving the digestive system. ...Saturday 30 November 2013
Drug Improves Remission of Crohn Disease Among Adolescents
Among adolescents with Crohn disease not responding to treatment, use of the drug thalidomide resulted in improved clinical remission after 8 weeks of treatment compared with placebo. This is according to a study appearing in the November 27 issue of iJAMA/i. As many as 1.2 million people in Europe and more than half a million in the United States are estimated to have Crohn disease, a chronic inflammatory disease involving the digestive system. ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment